Background. The development of adequate animal models is important for
the in vivo study of selected aspects of peritoneal dialysis (PD) tha
t cannot be evaluated by an in vitro model, such as peritoneal membran
e transport, the influence of local defense mechanisms, and for testin
g new osmotic agents and their bio-compatibilities. Methods. Our exper
ience with animal models for PD, including the acute Stockholm model i
n non-uremic rats, the acute and chronic Amsterdam model in non-uremic
rats, and the chronic Gent model in uremic rats, is described. Result
s. The Stockholm model proved to be useful in understanding the normal
physiology of peritoneal transport, and for testing new dialysis solu
tions and their biocompatibilities. It is a rather simple and inexpens
ive model, and thus is suitable for screening new solutions and additi
ves. The Amsterdam model permits the study of chemokines and mesotheli
al cell regeneration in vivo, and is applied in a model of chronic per
itonitis. The results of the Gent model suggest that chronic peritonea
l dialysis in uremic rats is feasible for at least eight weeks. This m
odel is, however, very laborious, time consuming, and expensive. Concl
usion. Further improvement of the technique and increase of the dialys
is dose should result in a better and more realistic model for periton
eal dialysis. It is hoped that in the future these models will be usef
ul to lest the effects of long-term intraperitoneal application of dif
ferent dialysis solutions and additives in uremic animals.